1Imagawa A, Hanafusa T, Uchigata Y, et al. Fulminant type 1 diabetes: a nationwide survey in Japan[J]. Diabetes Care, 2003, 26 (8): 2345-52.
2Imagawa A, Hanafusa T, Uchigata Y, et al. Fulminant type 1 Diabetologia, diabetes: a nativ nwidervey in Japan [J]. Diabetes Care, 2003, 26(5): 2345-52.
3Beard HA, Alghatrif M, Samper-Tement R, et al. American diabetes association, standards of medical care in diabetes[J]. Diabetes Care, 2012, 35(3): S11-61.
4Cbiou CC, Chung WH, Hung SI, et ai. Fulminant type 1 diabetes mellitus caused by drug hypersensitivity syndrome with human herpesvirus 6 infection[J]. J Am Acad Dermatol, 2006, 54(2 Suppl): S14-7.
5Yamanouchi T, Tachibana Y, Akanuma H, et al. Origin and disposal of 1,5-anhydroglucitol, a major polyol in the human body~J~. Am J Physiol, 1992, 263(2 Pt 1): E268-73.
6Yamanouchi T, Akanuma H, Nakamura T, et al. Reduction of plasma 1,5-anhydroglucitol (1-deoxyglucose) concentration in diabetic patients[J]. Diabetologia, 1988, 31(1): 41-5.
7Yamanouchi T, Ogata N, Tagaya T, et al. Clinical usefulness of serum 1,5-anhydroglucitol in monitoring glycaemic control [J]. Lancet, 1996, 347(914): 1514-8.
8Koga M, Murai J, Saito H, et al. Serum glycated albumin to hemoglobin A1C ratio is a suitable index for diagnosis of fulminant type 1 diabetes mellitus[J]. Ann Clin Biochem, 2010(47): 313-7.
